CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-30 | Ragard John Phillip Director | Option exercise · Restricted Stock Units | +4,844 | 14,531 | ||
| 2024-09-30 | Parnell Winfred Director | Option exercise | +5,156 | 55,740 | ||
| 2024-09-30 | Parnell Winfred Director | Option exercise · Restricted Stock Units | −5,156 | 15,469 | ||
| 2024-09-30 | Herchuk Jannie Prestridge Director | Option exercise | +8,438 | 57,190 | ||
| 2024-09-30 | Herchuk Jannie Prestridge Director | Option exercise · Restricted Stock Units | −8,438 | 25,312 | ||
| 2024-09-30 | Fralick Celeste Rachelle Director | Option exercise | +5,000 | 45,665 | ||
| 2024-09-30 | Fralick Celeste Rachelle Director | Option exercise · Restricted Stock Units | −5,000 | 15,000 | ||
| 2024-09-30 | Cavanaugh Stefanie L. Director | Option exercise | +5,938 | 60,914 | ||
| 2024-09-30 | Cavanaugh Stefanie L. Director | Option exercise · Restricted Stock Units | −5,938 | 17,812 | ||
| 2024-08-22 | Vos Ellen O'Connor Director | Grant or award · Restricted Stock Units | +21,250 | 21,250 | ||
| 2024-08-22 | Parnell Winfred Director | Grant or award · Restricted Stock Units | +20,625 | 20,625 | ||
| 2024-08-22 | Ragard John Phillip Director | Grant or award · Restricted Stock Units | +19,375 | 19,375 | ||
| 2024-08-22 | Herchuk Jannie Prestridge Director | Grant or award · Restricted Stock Units | +33,750 | 33,750 | ||
| 2024-08-22 | Fralick Celeste Rachelle Director | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2024-08-22 | Cavanaugh Stefanie L. Director | Grant or award · Restricted Stock Units | +23,750 | 23,750 | ||
| 2024-08-15 | Kallassy John A Interim CFO | Grant or award · Stock option (right to buy) | +25,000 | 25,000 | ||
| 2024-08-12 | Fralick Celeste Rachelle Director | Grant or award | +15,381 | 40,665 | ||
| 2024-08-12 | Parnell Winfred Director | Grant or award | +15,803 | 50,584 | ||
| 2024-08-12 | Herchuk Jannie Prestridge Director | Grant or award | +20,017 | 48,752 | ||
| 2024-08-12 | Cavanaugh Stefanie L. Director | Grant or award | +16,804 | 54,976 |
Page 5 of 15 · 296 trades